About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Access to Life Saving Drugs in Developing Countries may be Hurt by India-EU Deal

by Kathy Jones on March 25, 2011 at 9:51 PM
Font : A-A+

 Access to Life Saving Drugs in Developing Countries may be Hurt by India-EU Deal

A new trade agreement between India and Europe would block access to life saving drugs for billions of people living in developing countries, an expert has warned.

The EU wants India to adopt tough new patent protection rules for drugs so that no new generic drug could be sold in India without the permission of the company that owned the brand name version of the drug, said James Love at Knowledge Ecology International.

Advertisement

Not only would this have an enormous impact on the entire developing world, it would also dramatically shrink the global market for inexpensive generic drugs, warned Love.

It will also make a mockery of promises made by EU trade officials that governments would implement intellectual property rules in such a way to "protect public health and, in particular, to promote access to medicines for all."
Advertisement

In 1970, India eliminated patents on drug products, which enabled it to develop a strong generic drug industry. In 2005, India modified its patent law, to conform to the World Trade Organization (WTO) rules on the protection of intellectual property. But in doing so, India provide certain safeguards to make it easier to continue to manufacture generic medicines.

Now Europe wants India to adopt strict intellectual property protection rules that go beyond its obligations at the WTO, and which will effectively remove India as a legal market for early production of generic drugs. It will also restrict other developing countries access to much-needed supplies of affordable drugs.

Furthermore, the EU is currently negotiating this agreement with India in secret, despite its potential impact on billions of people living in developing countries, said author.

"Political and civic leaders from Europe and around the world must appeal to the EU to avoid outcomes that make it even more difficult to manufacture and market inexpensive drugs in developing countries," argued Love.

"This can begin by eliminating demands that India adopt exclusive rights on drug test data, or lower its standards for granting patents on medical inventions," added Love.

The report has been published on bmj.com.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test  Your Knowledge on Heart
Test Your Knowlege on Genes
Obesity in Teens Make Inroads into Early Atrial Fibrillation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Drugs Banned in India 

Most Popular on Medindia

Iron Intake Calculator Accident and Trauma Care Noscaphene (Noscapine) Post-Nasal Drip Blood Pressure Calculator Find a Hospital Color Blindness Calculator Blood Donation - Recipients Hearing Loss Calculator Indian Medical Journals
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Access to Life Saving Drugs in Developing Countries may be Hurt by India-EU Deal Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests